Article
Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologics
1 Aug 2023
Abstract excerpt
BACKGROUND: Few studies have explored the immunology and genetic risk of paradoxical eczema occurring as an adverse event of biologic therapy in patients with psoriasis. OBJECTIVES: We sought to describe the systemic inflammatory signature of paradoxical eczema using proteomics and explore whether this is genetically mediated. METHODS: This study used the Olink Target 96 Inflammation panel on 256 serum samples...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
